サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1571826

マラリア診断の市場規模、シェア、動向分析レポート：技術別、最終用途別、地域別、セグメント予測、2024年～2030年

Malaria Diagnostics Market Size, Share & Trends Analysis Report By Technology (Microscopy, Rapid Diagnostic Tests), By End Use (Clinics, Hospitals), By Region, And Segment Forecasts, 2024 - 2030

出版日
ページ情報
英文 125 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
マラリア診断の市場規模、シェア、動向分析レポート：技術別、最終用途別、地域別、セグメント予測、2024年～2030年
出版日: 2024年09月25日
発行: Grand View Research
ページ情報: 英文 125 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

マラリア診断市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界のマラリア診断の市場規模は、2024年から2030年にかけてCAGR2.6％で拡大し、2030年までには9億50万米ドルに達すると予測されています。

流行国における熱帯病の流行増加、新規診断技術の市場開拓、地域政府や民間投資家による投資の増加が市場成長を促進すると予測されています。マラリアは、気候の変化、低経済成長、未発達のヘルスケアインフラ、高度な治療へのアクセス不足などの理由から、熱帯および亜熱帯地域で一般的に発生する、最も広く普及している生命を脅かす病気の1つです。

政府のイニシアティブや市場参入企業による投資の増加も、近い将来の市場成長を促進すると予想されています。COVID-19の大流行時には、アフリカ地域で豊富に入手可能な抗マラリア治療オプションが、感染拡大の管理・抑制に使用されました。COVID-19ウイルスに加えてマラリア症例が増加し続けたため、COVID-19の大流行時に市場は大きく盛り上がりました。

この病気の流行を抑えるため、大手企業によって多くのマラリア撲滅プログラムが実施されています。例えば、Novartisのマラリア・イニシアティブは、マラリアの撲滅と制御を促進することを目的としています。様々な組織とともに、同社は60カ国で7億5,000万人に非営利治療を提供してきました。このような取り組みにより、新規技術の開拓が促進され、市場浸透の一助となることが期待されます。

マラリア診断市場のレポートハイライト

  • マラリア原虫の検出には従来から顕微鏡検査が使用されており、顕微鏡検査技術分野を牽引しています。
  • RDTは、使いやすさ、利便性、迅速診断により、最大の売上シェアを占めると予測されます。
  • 分子診断検査分野は、その精度と低寄生虫数の検出能力により、予測期間中に最も急成長する技術分野と予測されます。
  • アフリカは、高い罹患率と様々なマラリア診断技術の採用増加により、2023年の市場をリードしました。
  • 東南アジアは、病気の再発が多く、マラリア罹患を抑制するための取り組みが行われているため、CAGR2.3%で成長すると予測されます。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 マラリア診断市場の変数、動向、範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連 / 付随市場の見通し
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • マラリア診断市場分析ツール
    • 業界分析 - ポーターのファイブフォース分析
    • PESTEL分析

第4章 マラリア診断市場：技術の推定・動向分析

  • 技術市場シェア、2023年・2030年
  • セグメントダッシュボード
  • 世界のマラリア診断市場：技術展望別
  • 市場規模・予測と動向分析、2018年～2030年

第5章 マラリア診断市場：最終用途の推定・動向分析

  • メソッド市場シェア、2023年・2030年
  • セグメントダッシュボード
  • 世界のマラリア診断市場展望：最終用途別
  • 市場規模・予測と動向分析、2018年～2030年

第6章 マラリア診断市場：地域の推定・動向分析

  • 地域別市場シェア分析、2023年・2030年
  • 地域市場ダッシュボード
  • 世界の地域市場のスナップショット
  • 市場規模、予測動向分析、2018年～2030年：
  • アフリカ
    • ナイジェリア
    • コンゴ民主共和国
    • タンザニア連合共和国
    • ウガンダ
    • 南アフリカ
    • モザンビーク
    • アンゴラ
    • ガーナ
    • ボツワナ
    • ナミビア
  • 東南アジア
    • インド
    • ミャンマー
    • インドネシア
  • 東地中海
    • サウジアラビア
    • パキスタン
  • 西太平洋
    • 中国
    • パプアニューギニア
    • カンボジア
  • 南北アメリカ
    • ベネズエラ
    • ブラジル
    • コロンビア
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • トルコ

第7章 競合情勢

  • 最近の動向と影響分析：主要市場参入企業別
  • 企業 / 競合の分類
  • ベンダー情勢
    • 主要販売代理店・チャネルパートナーのリスト
    • 主要顧客
    • 主要企業の市場シェア分析、2023年
    • Access Bio, Inc.
    • Abbott Laboratories
    • Premier Medical Corporation Pvt. Ltd.
    • Sysmex Partec GmbH
    • Siemens Healthineers
    • bioMerieux
    • Beckman Coulter, Inc.
    • Leica Microsystems GmbH
    • Bio-Rad Laboratories, Inc.
図表

List of Tables

  • Table 1 List of Abbreviation
  • Table 2 Africa malaria diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 3 Africa malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 4 Africa malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 5 Nigeria malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 6 Nigeria malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 7 Democratic Republic of Congo malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 8 Democratic Republic of Congo malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 9 Uganda malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 10 Uganda malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 11 United Republic of Tanzania malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 12 United Republic of Tanzania malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 13 South Africa malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 14 South Africa malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 15 Mozambique malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 16 Mozambique malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 17 Angola malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 18 Angola malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 19 Ghana malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 20 Ghana malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 21 Botswana malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 22 Botswana malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 23 Namibia malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 24 Namibia malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 25 South East Asia malaria diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 26 South East Asia malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 27 South East Asia malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 28 India malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 29 India malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 30 Myanmar malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 31 Myanmar malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 32 Indonesia malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 33 Indonesia malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 34 Eastern Mediterranean malaria diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 35 Eastern Mediterranean malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 36 Eastern Mediterranean malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 37 Saudi Arabia malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 38 Saudi Arabia malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 39 Pakistan malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 40 Pakistan malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 41 Western Pacific malaria diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 42 Western Pacific malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 43 Western Pacific malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 44 China malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 45 China malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 46 Papua New Guinea malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 47 Papua New Guinea malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 48 Cambodia malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 49 Cambodia malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 50 Americas malaria diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 51 Americas malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 52 Americas malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 53 Venezuela malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 54 Venezuela malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 55 Brazil malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 56 Brazil malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 57 Colombia malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 58 Colombia malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 59 Europe malaria diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 60 Europe malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 61 Europe malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 62 Turkey malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 63 Turkey malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 64 France malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 65 France malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 66 UK malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 67 UK malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 68 Germany malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 69 Germany malaria diagnostics market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in Africa
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in South East Asia
  • Fig. 7 Primary interviews in Eastern Mediterranean
  • Fig. 8 Primary interviews in Western Pacific
  • Fig. 9 Primary interviews in Americas
  • Fig. 10 Primary interviews in Europe
  • Fig. 11 Market research approaches
  • Fig. 12 Value-chain-based sizing & forecasting
  • Fig. 13 QFD modeling for market share assessment
  • Fig. 14 Market formulation & validation
  • Fig. 15 Malaria Diagnostics market: market outlook
  • Fig. 16 Malaria Diagnostics competitive insights
  • Fig. 17 Parent market outlook
  • Fig. 18 Related/ancillary market outlook
  • Fig. 19 Penetration and growth prospect mapping
  • Fig. 20 Industry value chain analysis
  • Fig. 21 Malaria Diagnostics market driver impact
  • Fig. 22 Malaria Diagnostics market restraint impact
  • Fig. 23 Malaria Diagnostics market strategic initiatives analysis
  • Fig. 24 Malaria Diagnostics market: Technology movement analysis
  • Fig. 25 Malaria Diagnostics market: Technology outlook and key takeaways
  • Fig. 26 Molecular Diagnostic Tests market estimates and forecasts, 2018 - 2030
  • Fig. 27 Conventional PCR market estimates and forecasts, 2018 - 2030
  • Fig. 28 Modernized PCR market estimates and forecasts, 2018 - 2030
  • Fig. 29 Microscopy market estimates and forecasts, 2018 - 2030
  • Fig. 30 Rapid Diagnostic Tests (RDT) market estimates and forecasts, 2018 - 2030
  • Fig. 31 Malaria Diagnostics market: End Use movement analysis
  • Fig. 32 Malaria Diagnostics market: End Use outlook and key takeaways
  • Fig. 33 Hospitals & Clinics market estimates and forecasts, 2018 - 2030
  • Fig. 34 Diagnostic Centers market estimates and forecasts, 2018 - 2030
  • Fig. 35 Academic and Research Institutes market estimates and forecasts, 2018 - 2030
  • Fig. 36 Global malaria diagnostics market: Regional movement analysis
  • Fig. 37 Global malaria diagnostics market: Regional outlook and key takeaways
  • Fig. 38 Global malaria diagnostics market share and leading players
  • Fig. 39 Africa market share and leading players
  • Fig. 40 Europe market share and leading players
  • Fig. 41 South East Asia market share and leading players
  • Fig. 42 Eastern Mediterranean market share and leading players
  • Fig. 43 Western Pacific market share and leading players
  • Fig. 44 Americas market share and leading players
  • Fig. 45 Africa market estimates and forecasts, 2018 - 2030
  • Fig. 46 Nigeria market estimates and forecasts, 2018 - 2030
  • Fig. 47 Democratic Republic of Congo market estimates and forecasts, 2018 - 2030
  • Fig. 48 Uganda market estimates and forecasts, 2018 - 2030
  • Fig. 49 United Republic of Tanzania market estimates and forecasts, 2018 - 2030
  • Fig. 50 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 51 Mozambique market estimates and forecasts, 2018 - 2030
  • Fig. 52 Angola market estimates and forecasts, 2018 - 2030
  • Fig. 53 Ghana market estimates and forecasts, 2018 - 2030
  • Fig. 54 Botswana market estimates and forecasts, 2018 - 2030
  • Fig. 55 Namibia market estimates and forecasts, 2018 - 2030
  • Fig. 56 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 57 UK market estimates and forecasts, 2018 - 2030
  • Fig. 58 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 59 France market estimates and forecasts, 2018 - 2030
  • Fig. 60 Turkey market estimates and forecasts, 2018 - 2030
  • Fig. 61 South East Asia market estimates and forecasts, 2018 - 2030
  • Fig. 62 India market estimates and forecasts, 2018 - 2030
  • Fig. 63 Myanmar market estimates and forecasts, 2018 - 2030
  • Fig. 64 Indonesia market estimates and forecasts, 2018 - 2030
  • Fig. 65 Eastern Mediterranean market estimates and forecasts, 2018 - 2030
  • Fig. 66 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 67 Pakistan market estimates and forecasts, 2018 - 2030
  • Fig. 68 Western Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 69 China market estimates and forecasts, 2018 - 2030
  • Fig. 70 Papua New Guinea market estimates and forecasts, 2018 - 2030
  • Fig. 71 Cambodia market estimates and forecasts, 2018 - 2030
  • Fig. 72 Americas market estimates and forecasts, 2018 - 2030
  • Fig. 73 Venezuela market estimates and forecasts, 2018 - 2030
  • Fig. 74 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 75 Colombia market estimates and forecasts, 2018 - 2030
  • Fig. 76 Market share of key market players- Malaria Diagnostics market
目次
Product Code: 978-1-68038-711-7

Malaria Diagnostics Market Growth & Trends:

The global malaria diagnostics market size is projected to reach USD 900.5 million by 2030, expanding at a CAGR of 2.6% from 2024 to 2030, according to a new report by Grand View Research, Inc. Rising prevalence of the tropical disease in endemic countries, development of novel diagnostic techniques, and rising investments by regional governments and private investors are expected to propel market growth. Malaria is one of the most widespread life-threatening diseases, commonly occurring in the tropical and subtropical regions due to changing climate, low economic growth, underdeveloped healthcare infrastructure, and lack of access to advanced treatment.

Increasing number of government initiatives and investments by market participants are also anticipated to fuel market growth in the near future. Use of antimalarial treatments options that were abundantly available in the African region were used for the management and control of spread during the COVID-19 pandemic. The market noticed a significant boost during the COVID-19 outbreak owing to the ever-increasing malaria cases in addition to the COVID-19 virus.

A large number of malarial elimination programs are being undertaken by major companies to reduce the disease prevalence. For instance, Novartis's Malaria Initiative was aimed at facilitating malaria elimination and control. Along with various organizations, the company has provided non-profit treatment to 750 million people across 60 countries. Thus, such initiatives are anticipated to facilitate the development of novel technologies and aid in market penetration.

Malaria Diagnostics Market Report Highlights:

  • Conventional usage of microscopic examination for detection of malarial parasite has driven the microscopy technology segment
  • RDTs are anticipated to account for the largest revenue share owing to ease of usage, convenience, and rapid diagnosis.
  • The molecular diagnostic tests segment is projected to be the fastest-growing technology segment during the forecast period owing to their accuracy and capability of detecting low parasite count.
  • Africa led the market in 2023 due to high disease incidence and increased adoption of various malarial diagnostic techniques in the region.
  • Southeast Asia is expected to grow at a CAGR of 2.3% owing to high disease reoccurrence and initiatives undertaken to curb malarial incidence.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Technology
    • 1.2.2. End Use
    • 1.2.3. Regional scope
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Technology outlook
    • 2.2.2. End Use outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Malaria Diagnostics Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing demand for diagnostic tools in malaria-endemic countries
      • 3.2.1.2. Development of technologically advanced and efficient diagnostics
      • 3.2.1.3. Market players and private investors to curb the prevalence of malaria
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Increasing number of countries in the malaria elimination phase
      • 3.2.2.2. Demand for low-cost malaria diagnostic tests
  • 3.3. Malaria Diagnostics Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Malaria Diagnostics Market: Technology Estimates & Trend Analysis

  • 4.1. Technology Market Share, 2023 & 2030
  • 4.2. Segment Dashboard
  • 4.3. Global Malaria Diagnostics Market by Technology Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.4.1. Molecular Diagnostic Tests
      • 4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.1.2. Conventional PCR
        • 4.4.1.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.1.3. Modernized PCR
        • 4.4.1.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2. Microscopy
      • 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.3. Rapid Diagnostic Tests (RDT)

Chapter 5. Malaria Diagnostics Market: End Use Estimates & Trend Analysis

  • 5.1. Method Market Share, 2023 & 2030
  • 5.2. Segment Dashboard
  • 5.3. Global Malaria Diagnostics Market by End Use Outlook
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.4.1. Hospitals & Clinics
      • 5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
    • 5.4.2. Diagnostic Centers
      • 5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.3. Academic and Research Institutes
      • 5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Malaria Diagnostics Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Market Share Analysis, 2023 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. Global Regional Market Snapshot
  • 6.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 6.5. Africa
    • 6.5.1. Nigeria
      • 6.5.1.1. Key country dynamics
      • 6.5.1.2. Regulatory framework/ reimbursement structure
      • 6.5.1.3. Competitive scenario
      • 6.5.1.4. Nigeria market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.2. Democratic Republic of the Congo
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Regulatory framework/ reimbursement structure
      • 6.5.2.3. Competitive scenario
      • 6.5.2.4. Democratic Republic of the Congo market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.3. United Republic of Tanzania
      • 6.5.3.1. Key country dynamics
      • 6.5.3.2. Regulatory framework/ reimbursement structure
      • 6.5.3.3. Competitive scenario
      • 6.5.3.4. United Republic of Tanzania market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.4. Uganda
      • 6.5.4.1. Key country dynamics
      • 6.5.4.2. Regulatory framework/ reimbursement structure
      • 6.5.4.3. Competitive scenario
      • 6.5.4.4. Uganda market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.5. South Africa
      • 6.5.5.1. Key country dynamics
      • 6.5.5.2. Regulatory framework/ reimbursement structure
      • 6.5.5.3. Competitive scenario
      • 6.5.5.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.6. Mozambique
      • 6.5.6.1. Key country dynamics
      • 6.5.6.2. Regulatory framework/ reimbursement structure
      • 6.5.6.3. Competitive scenario
      • 6.5.6.4. Mozambique market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.7. Angola
      • 6.5.7.1. Key country dynamics
      • 6.5.7.2. Regulatory framework/ reimbursement structure
      • 6.5.7.3. Competitive scenario
      • 6.5.7.4. Angola market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.8. Ghana
      • 6.5.8.1. Key country dynamics
      • 6.5.8.2. Regulatory framework/ reimbursement structure
      • 6.5.8.3. Competitive scenario
      • 6.5.8.4. Ghana market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.9. Botswana
      • 6.5.9.1. Key country dynamics
      • 6.5.9.2. Regulatory framework/ reimbursement structure
      • 6.5.9.3. Competitive scenario
      • 6.5.9.4. Botswana market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.10. Namibia
      • 6.5.10.1. Key country dynamics
      • 6.5.10.2. Regulatory framework/ reimbursement structure
      • 6.5.10.3. Competitive scenario
      • 6.5.10.4. Namibia market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. South East Asia
    • 6.6.1. India
      • 6.6.1.1. Key country dynamics
      • 6.6.1.2. Regulatory framework/ reimbursement structure
      • 6.6.1.3. Competitive scenario
      • 6.6.1.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.2. Myanmar
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Regulatory framework/ reimbursement structure
      • 6.6.2.3. Competitive scenario
      • 6.6.2.4. Myanmar market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.3. Indonesia
      • 6.6.3.1. Key country dynamics
      • 6.6.3.2. Regulatory framework/ reimbursement structure
      • 6.6.3.3. Competitive scenario
      • 6.6.3.4. Indonesia market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7. Eastern Mediterranean
    • 6.7.1. Saudi Arabia
      • 6.7.1.1. Key country dynamics
      • 6.7.1.2. Regulatory framework/ reimbursement structure
      • 6.7.1.3. Competitive scenario
      • 6.7.1.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.2. Pakistan
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Regulatory framework/ reimbursement structure
      • 6.7.2.3. Competitive scenario
      • 6.7.2.4. Pakistan market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.8. Western Pacific
    • 6.8.1. China
      • 6.8.1.1. Key country dynamics
      • 6.8.1.2. Regulatory framework/ reimbursement structure
      • 6.8.1.3. Competitive scenario
      • 6.8.1.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.8.2. Papua New Guinea
      • 6.8.2.1. Key country dynamics
      • 6.8.2.2. Regulatory framework/ reimbursement structure
      • 6.8.2.3. Competitive scenario
      • 6.8.2.4. Papua New Guinea market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.8.3. Cambodia
      • 6.8.3.1. Key country dynamics
      • 6.8.3.2. Regulatory framework/ reimbursement structure
      • 6.8.3.3. Competitive scenario
      • 6.8.3.4. Cambodia market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.9. Americas
    • 6.9.1. Venezuela
      • 6.9.1.1. Key country dynamics
      • 6.9.1.2. Regulatory framework/ reimbursement structure
      • 6.9.1.3. Competitive scenario
      • 6.9.1.4. Venezuela market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.9.2. Brazil
      • 6.9.2.1. Key country dynamics
      • 6.9.2.2. Regulatory framework/ reimbursement structure
      • 6.9.2.3. Competitive scenario
      • 6.9.2.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.9.3. Colombia
      • 6.9.3.1. Key country dynamics
      • 6.9.3.2. Regulatory framework/ reimbursement structure
      • 6.9.3.3. Competitive scenario
      • 6.9.3.4. Colombia market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.10. Europe
    • 6.10.1. UK
      • 6.10.1.1. Key country dynamics
      • 6.10.1.2. Regulatory framework/ reimbursement structure
      • 6.10.1.3. Competitive scenario
      • 6.10.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.10.2. Germany
      • 6.10.2.1. Key country dynamics
      • 6.10.2.2. Regulatory framework/ reimbursement structure
      • 6.10.2.3. Competitive scenario
      • 6.10.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.10.3. France
      • 6.10.3.1. Key country dynamics
      • 6.10.3.2. Regulatory framework/ reimbursement structure
      • 6.10.3.3. Competitive scenario
      • 6.10.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.10.4. Turkey
      • 6.10.4.1. Key country dynamics
      • 6.10.4.2. Regulatory framework/ reimbursement structure
      • 6.10.4.3. Competitive scenario
      • 6.10.4.4. Turkey market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
  • 7.3. Vendor Landscape
    • 7.3.1. List of key distributors and channel partners
    • 7.3.2. Key customers
    • 7.3.3. Key company market share analysis, 2023
    • 7.3.4. Access Bio, Inc.
      • 7.3.4.1. Company overview
      • 7.3.4.2. Financial performance
      • 7.3.4.3. Product benchmarking
      • 7.3.4.4. Strategic initiatives
    • 7.3.5. Abbott Laboratories
      • 7.3.5.1. Company overview
      • 7.3.5.2. Financial performance
      • 7.3.5.3. Product benchmarking
      • 7.3.5.4. Strategic initiatives
    • 7.3.6. Premier Medical Corporation Pvt. Ltd.
      • 7.3.6.1. Company overview
      • 7.3.6.2. Financial performance
      • 7.3.6.3. Product benchmarking
      • 7.3.6.4. Strategic initiatives
    • 7.3.7. Sysmex Partec GmbH
      • 7.3.7.1. Company overview
      • 7.3.7.2. Financial performance
      • 7.3.7.3. Product benchmarking
      • 7.3.7.4. Strategic initiatives
    • 7.3.8. Siemens Healthineers
      • 7.3.8.1. Company overview
      • 7.3.8.2. Financial performance
      • 7.3.8.3. Product benchmarking
      • 7.3.8.4. Strategic initiatives
    • 7.3.9. bioMerieux
      • 7.3.9.1. Company overview
      • 7.3.9.2. Financial performance
      • 7.3.9.3. Product benchmarking
      • 7.3.9.4. Strategic initiatives
    • 7.3.10. Beckman Coulter, Inc.
      • 7.3.10.1. Company overview
      • 7.3.10.2. Financial performance
      • 7.3.10.3. Product benchmarking
      • 7.3.10.4. Strategic initiatives
    • 7.3.11. Leica Microsystems GmbH
      • 7.3.11.1. Company overview
      • 7.3.11.2. Financial performance
      • 7.3.11.3. Product benchmarking
      • 7.3.11.4. Strategic initiatives
    • 7.3.12. Bio-Rad Laboratories, Inc.
      • 7.3.12.1. Company overview
      • 7.3.12.2. Financial performance
      • 7.3.12.3. Product benchmarking
      • 7.3.12.4. Strategic initiatives